Search Results - "Stranz, Bettina"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer by Partl, Richard, Paal, Katarzyna, Stranz, Bettina, Hassler, Eva, Magyar, Marton, Brunner, Thomas Baptist, Langsenlehner, Tanja

    Published in Diagnostics (Basel) (01-02-2023)
    “…Chronic inflammatory reactions have been proven to represent relevant mechanisms for the development and progression of cancer in numerous tumor entities…”
    Get full text
    Journal Article
  2. 2

    Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer? by Partl, Richard, Lukasiak, Katarzyna, Stranz, Bettina, Hassler, Eva, Magyar, Marton, Stranzl-Lawatsch, Heidi, Langsenlehner, Tanja

    Published in Diagnostics (Basel) (25-05-2021)
    “…There is evidence suggesting that pre-treatment clinical parameters can predict the probability of sphincter-preserving surgery in rectal cancer; however, to…”
    Get full text
    Journal Article
  3. 3

    Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients by Paal, Katarzyna, Stranz, Bettina, Thurner, Eva-Maria, Langsenlehner, Uwe, Renner, Wilfried, Brunner, Thomas Baptist, Langsenlehner, Tanja

    Published in Strahlentherapie und Onkologie (01-03-2024)
    “…Purpose The purpose of the present prospective study was to evaluate the significance of geriatric conditions measured by a comprehensive geriatric assessment…”
    Get full text
    Journal Article
  4. 4

    Effects of proteolytic enzyme therapy with Wobe Mugos against chemotherapy-induced toxicity in breast cancer patients - results of a pilot study by Petru, Edgar, Stranz, Bettina, Petru, Claudia

    Published in Wiener medizinische Wochenschrift (01-11-2010)
    “…Wobe Mugos(®) is an enzyme preparation containing the proteases trypsin and papain from the pancreatic calf and commonly used in complementary medicine. From…”
    Get full text
    Journal Article
  5. 5

    Proteolytische Enzymtherapie mit Wobe Mugos® gegen Chemotherapie-bedingte Toxizitäten bei Brustkrebs-Patientinnen – Ergebnisse einer Pilotstudie by Petru, Edgar, Stranz, Bettina, Petru, Claudia

    Published in Wiener medizinische Wochenschrift (01-11-2010)
    “…Zusammenfassung GRUNDLAGEN: Wobe Mugos ® ist ein häufig verwendetes komplementäres Enzympräparat, welches aus den Proteasen Trypsin und Papain des…”
    Get full text
    Journal Article